Optimal treatment approach for intracranial germinoma: a systematic review and meta-analysis

Zhirui Zhou1,2,3, Jiabing Liu4,5, Qi Yue5,6

  • 1Radiation Oncology Center, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, 200040, China. zzr3711@163.com.

BMC Cancer
|January 8, 2025
PubMed
Abstract

Insights

Focal field radiotherapy is not recommended for intracranial germinoma. Whole ventricles irradiation offers better local control than reduced-field radiotherapy for localized disease, while reduced-dose craniospinal irradiation is effective for metastatic germinoma.

Area of Science:

  • Neuro-oncology
  • Radiation oncology
  • Pediatric oncology

Background:

  • Intracranial germinoma (IG) treatment requires optimal modality selection.
  • Understanding treatment efficacy and toxicity is crucial for patient outcomes.

Approach:

  • Systematic review and meta-analysis of 37 studies.
  • Pooled risk ratios (RR) and 95% confidence intervals (CI) were calculated.
  • Subgroup analysis compared radiotherapy (RT) alone versus RT with chemotherapy (CTx).

Key Points:

  • Focal field RT showed higher recurrence rates than craniospinal irradiation (CSI), whole-brain RT (WBRT), or whole-ventricle RT (WVRT).
  • WBRT and WVRT had higher recurrence than CSI, with no significant difference between WBRT and WVRT.
  • Combination CTx increased acute toxicity; expanded RT fields/doses increased late toxicity.

Conclusions:

  • Focal field RT is not recommended for intracranial pure germinoma.
  • Whole ventricles irradiation is a reasonable option for localized/nonmetastatic germinoma, balancing local control and toxicity.
  • Reduced-dose CSI with or without chemotherapy is effective for metastatic/disseminated IG.

Related Concept Videos